Abstract
The prospect of precision or personalized medicine has revived the entire field of predictive drug testing originally pursued in clonogenic assays and soft agar colony forming assays some four decades ago [1]. In particular, the human breast and its derived tumors, while relatively trivial in composition,have proven enormously difficult to establish and interpret ex vivo.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
